Fred Hutchinson Cancer Center (FHCC) — Seattle, Washington

Fred Hutchinson Cancer Center (FHCC) is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Fred Hutchinson Cancer Center (FHCC) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Newly Diagnosed Glioblastoma, Graft vs Host Disease.

Sponsors: MimiVax, LLC, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred Hutchinson Cancer Center (FHCC)?

Fred Hutchinson Cancer Center (FHCC) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred Hutchinson Cancer Center (FHCC) conducted?

Fred Hutchinson Cancer Center (FHCC) has 2 clinical trials on record, with 1 currently active. Their work covers Newly Diagnosed Glioblastoma, Graft vs Host Disease.

Is Fred Hutchinson Cancer Center (FHCC) accredited by Crixeo Health?

Fred Hutchinson Cancer Center (FHCC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fred Hutchinson Cancer Center (FHCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.